
E-Panta Injection
Marketer
Ethics Health Care Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview E-Panta Injection
Pantaject, an intravenous medication, diminishes gastric acid production. It treats acid-related gastrointestinal disorders including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and promoting healing. Pantaject also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a healthcare provider only when deemed clinically preferable to oral formulations. Dosage is individualized based on patient response and condition, with treatment duration determined by the physician. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as frequent smaller meals and avoidance of caffeine, spices, and fatty foods, can enhance therapeutic efficacy. Common, typically mild, adverse effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical consultation. Prolonged use, particularly exceeding one year, especially at higher doses, may elevate the risk of bone fractures. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your physician. Pantaject is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if experiencing dizziness or somnolence.
Primary Ingredients of E-Panta Injection
No text was provided. Please provide the text you wish to be rewritten.
Uses of E-Panta Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of E-Panta Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of E-Panta Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use E-Panta Injection:
Administering this medication will be handled by your physician or their qualified assistant; self-medication is strongly discouraged.
How E-Panta Injection works:
Gastric acid production is decreased by E-Panta Injection, a proton pump inhibitor, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using E-Panta Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering E-Panta Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of E-Panta Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
E-Panta Injection's effect on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
E-Panta Injection poses no known safety concerns for individuals with renal impairment. No alteration of the E-Panta Injection dosage is advised.
LiverCAUTION
Administering E-Panta Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for E-Panta Injection might be necessary. Physician consultation is advised.
What if you forget to take E-Panta Injection :
Omitting a scheduled dose of E-Panta Injection warrants contacting your physician.
Facts to Know About E-Panta Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
